AbCellera Biologics Inc. ABCL Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
Based on trailing twelve months.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s free cash flow margin?
- AbCellera Biologics Inc. (ABCL) reported free cash flow margin of -238.9% in Q1 2026.
- How has AbCellera Biologics Inc.'s free cash flow margin changed year-over-year?
- AbCellera Biologics Inc.'s free cash flow margin increased by 61.5% year-over-year, from -619.9% to -238.9%.
- What is the long-term trend for AbCellera Biologics Inc.'s free cash flow margin?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s free cash flow margin has grown at a -14.6% compound annual growth rate (CAGR), from -317.7% to -231.7%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.